Basilea Pharmaceutica Ltd logo

Basilea Pharmaceutica Ltd (BSLN)

Market Closed
19 Jun, 15:20
SIX SIX
51. 30
CHF
+0.6
+1.1834%
CHF
615.02M Market Cap
7.96 P/E Ratio
20% Div Yield
38,585 Volume
2.9 Eps
50.7 CHF
Previous Close
Add Transaction
Day Range
50.3 51.5
Year Range
44.7 59.7
Want to track BSLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
16 Feb 2026
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
3 Dec 2025
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
19 Aug 2025
2.12
1.26
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
24 Apr 2025
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
11 Feb 2025
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
13 Aug 2024
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
24 Apr 2024
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
13 Feb 2024
0.93
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
29 Nov 2023
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
15 Aug 2016
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
29 Feb 2016
-
-
Basilea Pharmaceutica Ltd logo
BSLN Basilea Pharmaceutica Ltd
14 Aug 2015
-
-

BSLN Earnings Reports FAQ

What is the earnings per share (EPS) for BSLN?

The current EPS is 2.9.

What is the company's earnings growth rate?

Basilea Pharmaceutica Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Basilea Pharmaceutica Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Basilea Pharmaceutica Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for BSLN at this time, as Basilea Pharmaceutica Ltd has no recent EPS data to calculate it.